“…[52,58,66,67,72,106,112,115,124,137,141] as an outcome used mostly to analyse audit and feedback ASP [58,67,74,141]. In five cases, no changes were reported [58,66,74,106,115], while the other seven studies showed an increased susceptibility of the bacteria analysed [52,67,72,112,124,137,141]. The most interesting results were a decrease in extended spectrum beta-lactamase (ESBL) producers E. coli and K. pneumoniae [72,112,124]; a reduction in the rate of P. aeruginosa carbapenem resistance subsequent to an observed reduction in the rate of antimicrobial days of therapy (DOT) [67,124]; and, in two studies set in outpatient setting, an increase in erythromycin-sensitive S. pyogenes following a reduction in the use of macrolides [137,141].…”